Proton chemical shift imaging of bone marrow for monitoring therapy in leukemia.
In three patients with different forms of leukemia, follow-up examinations before, during, and after chemotherapy and bone marrow transplantation were performed by proton chemical shift imaging (1H-CSI). The relative fat and water fractions were computed in representative regions of the marrow in the femur, pelvis, and lumbar spine. On serial examinations the fat fractions increased over time, in agreement with the responses to therapy proven by bone marrow biopsies from the iliac crest. These preliminary results suggest a role for magnetic resonance and CSI in the monitoring of therapy in leukemia and systemic neoplastic diseases.
Gückel
F
F
German Cancer Research Center, Institute of Radiology and Pathophysiology, Heidelberg.
Brix
G
G
Semmler
W
W
Ho
A D
AD
Körbling
M
M
Georgi
M
M
van Kaick
G
G
D000208:Acute Disease; D000328:Adult; D001853:Bone Marrow / Q000473:pathology*; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000175:diagnosis* / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D015649:Pentostatin / Q000627:therapeutic use
D015649:Pentostatin; D003520:Cyclophosphamide